RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000077.xml
PDF herunterladen
CC BY-NC-ND 4.0 · Semin Thromb Hemost 2019; 45(05): 433-448
DOI: 10.1055/s-0039-1692700
DOI: 10.1055/s-0039-1692700
Review Article
Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
10. Juli 2019 (online)
Abstract
Many preanalytical variables may affect the results of routine coagulation assays. While advances in laboratory instrumentation have partially addressed the laboratory's ability to recognize some of these variables, there remains an increased reliance on laboratory personnel to recognize the three potential areas where coagulation testing preanalytical issues may arise: (1) specimen collection (including patient selection), (2) specimen transportation and stability, and (3) specimen processing and storage. The purpose of this article is to identify the preanalytical variables associated with coagulation-related testing and provide laboratory practice recommendations in an effort to improve the quality of coagulation testing and accuracy of result reporting.
-
References
- 1 Plebani M, Favaloro EJ, Lippi G. Patient safety and quality in laboratory and hemostasis testing: a renewed loop?. Semin Thromb Hemost 2012; 38 (06) 553-558
- 2 Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES, Srivastava A. Quality issues in laboratory haemostasis. Haemophilia 2010; 16 (Suppl. 05) 93-99
- 3 Adcock Funk DM, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation, and storage in hemostasis testing. Semin Thromb Hemost 2012; 38 (06) 576-585
- 4 Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?. Semin Thromb Hemost 2008; 34 (07) 612-634
- 5 Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med (Zagreb) 2010; 20: 184-199
- 6 Clinical and Laboratory Standards Institute (CLSI). Available at: https://clsi.org/ . Accessed March 09, 2019
- 7 International Organization for Standardization (ISO) document ISO 15189: 2012 . Medical laboratories— particular requirements for quality and competence. International Organization for Standardization, Geneva, Switzerland
- 8 United States Food and Drug Administration (FDA). Bioanalytical method validation guidance for industry. May 2018. Available at: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf . Accessed March 2019
- 9 Validation of analytical procedures: Text and methodology Q2(R1). ICH harmonised tripartite guideline. Available at: https://www.ich.org/products/guidelines/quality/article/quality-guidelines.html . Accessed March 2019
- 10 FDA Guidance for Industry Q2B Validation of Analytical Procedures: Methodology. 1996 . Available at: https://www.fda.gov/downloads/drugs/guidances/ucm073384.pdf . Accessed March 2019
- 11 Clinical laboratory improvement amendments of 1988: Final Rule. (42 CFR Part 405) Fed Reg 57:7001-7186. February 1992
- 12 Thompson, Michael & Ellison, Stephen & Wood, Roger. (2002). Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report). Pure and Applied Chemistry - PURE APPL CHEM. 74. 835-855. DOI: 10.1351/pac200274050835 [epub ahead of print]
- 13 Magnusson B, Örnemark U. , eds. Eurachem Guide: The Fitness for Purpose of Analytical Methods – A Laboratory Guide to Method Validation and Related Topics. 2nd ed. 2014 . ISBN 978-91-87461-59-0. Available at: www.eurachem.org . Accessed May 27, 2019
- 14 Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr. 2**. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf . Accessed March 2019
- 15 Favaloro EJ, Gosselin R, Olson J, Jennings I, Lippi G. Recent initiatives in harmonization of hemostasis practice. Clin Chem Lab Med 2018; 56 (10) 1608-1619
- 16 Toulon P. Developmental hemostasis: laboratory and clinical implications. Int J Lab Hematol 2016; 38 (Suppl. 01) 66-77
- 17 Nowak-Göttl U, Limperger V, Kenet G. , et al. Developmental hemostasis: a lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13
- 18 Righini M, Nendaz M, Le Gal G, Bounameaux H, Perrier A. Influence of age on the cost-effectiveness of diagnostic strategies for suspected pulmonary embolism. J Thromb Haemost 2007; 5 (09) 1869-1877
- 19 Giansante C, Fiotti N, Cattin L, Da Col PG, Calabrese S. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors. Thromb Haemost 1994; 71 (05) 581-586
- 20 Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol 2005; 124 (06) 910-917 Erratum in: Am J Clin Pathol. 2006;125(5):796
- 21 Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis 2005; 16 (08) 597-605
- 22 Ng KF. Changes in thrombelastograph variables associated with aging. Anesth Analg 2004; 99 (02) 449-454
- 23 Schneider T, Siegemund T, Siegemund R, Petros S. Thrombin generation and rotational thromboelastometry in the healthy adult population. Hamostaseologie 2015; 35 (02) 181-186
- 24 Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 2007; 105 (06) 1610-1613
- 25 Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Laboratory identification of familial thrombophilia: do the pitfalls exceed the benefits? A reassessment of ABO-blood group, gender, age, and other laboratory parameters on the potential influence on a diagnosis of protein C, protein S, and antithrombin deficiency and the potential high risk of a false positive diagnosis. Lab Hematol 2005; 11 (03) 174-184
- 26 Haubelt H, Anders C, Vogt A, Hoerdt P, Seyfert UT, Hellstern P. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals. Br J Haematol 2005; 130 (05) 759-767
- 27 Lindberg UB, Crona N, Stigendal L, Teger-Nilsson AC, Silfverstolpe G. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost 1989; 61 (01) 65-69
- 28 Blombäck M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R. ; ISTH SSC Subcommittee on Women's Health Issues. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 2007; 5 (04) 855-858
- 29 Knol HM, Kemperman RF, Kluin-Nelemans HC, Mulder AB, Meijer K. Haemostatic variables during normal menstrual cycle. A systematic review. Thromb Haemost 2012; 107 (01) 22-29
- 30 Chaireti R, Gustafsson KM, Byström B, Bremme K, Lindahl TL. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle. Hum Reprod 2013; 28 (07) 1846-1852
- 31 Karlsson O, Sporrong T, Hillarp A, Jeppsson A, Hellgren M. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg 2012; 115 (04) 890-898
- 32 Ataullakhanov FI, Koltsova EM, Balandina AN, Serebriyskiy II, Vuimo TA, Panteleev MA. Classic and global hemostasis testing in pregnancy and during pregnancy complications. Semin Thromb Hemost 2016; 42 (07) 696-716
- 33 Fredrik Blomqvist LR, Strandell AM, Baghaei F, Elisabet Hellgren MS. Platelet aggregation in healthy women during normal pregnancy - a longitudinal study. Platelets 2018; 16: 1-7
- 34 Kulkarni AA, Osmond M, Bapir M. , et al. The effect of labour on the coagulation system in the term neonate. Haemophilia 2013; 19 (04) 533-538
- 35 Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism. Thromb Haemost 2015; 114 (05) 901-909
- 36 Bryant A, Mhyre JM, Leffert LR, Hoban RA, Yakoob MY, Bateman BT. The association of maternal race and ethnicity and the risk of postpartum hemorrhage. Anesth Analg 2012; 115 (05) 1127-1136
- 37 Ho P, Ng C, Rigano J. , et al. Significant age, race and gender differences in global coagulation assays parameters in the normal population. Thromb Res 2017; 154: 80-83
- 38 Flood VH, Gill JC, Morateck PA. , et al. Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. Blood 2010; 116 (02) 280-286
- 39 Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemost 2013; 39 (06) 621-631
- 40 van Mens TE, Levi M, Middeldorp S. Evolution of factor V Leiden. Thromb Haemost 2013; 110 (01) 23-30
- 41 Colombatti R, De Bon E, Bertomoro A. , et al. Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy. PLoS One 2013; 8 (10) e78801
- 42 Hamer M, Gibson EL, Vuononvirta R, Williams E, Steptoe A. Inflammatory and hemostatic responses to repeated mental stress: individual stability and habituation over time. Brain Behav Immun 2006; 20 (05) 456-459
- 43 Geiser F, Meier C, Wegener I. , et al. Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom 2008; 77 (06) 377-383
- 44 Geiser F, Conrad R, Imbierowicz K. , et al. Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants. Psychiatry Clin Neurosci 2011; 65 (05) 518-525
- 45 Horacek J, Maly J, Svilias I. , et al. Prothrombotic changes due to an increase in thyroid hormone levels. Eur J Endocrinol 2015; 172 (05) 537-542
- 46 Van Zaane B, Squizzato A, Debeij J. , et al. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study. J Thromb Haemost 2011; 9 (09) 1816-1824
- 47 Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Exp Clin Endocrinol Diabetes 2008; 116 (10) 619-624
- 48 Ramaker AJ, Meyer P, van der Meer J. , et al. Effects of acidosis, alkalosis, hyperthermia and hypothermia on haemostasis: results of point-of-care testing with the thromboelastography analyser. Blood Coagul Fibrinolysis 2009; 20 (06) 436-439
- 49 de Maat MP, van Schie M, Kluft C, Leebeek FW, Meijer P. Biological variation of hemostasis variables in thrombosis and bleeding: consequences for performance specifications. Clin Chem 2016; 62 (12) 1639-1646
- 50 Rudez G, Meijer P, Spronk HM. , et al. Biological variation in inflammatory and hemostatic markers. J Thromb Haemost 2009; 7 (08) 1247-1255
- 51 Vandiver JW, Vondracek TG. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 2012; 32 (06) 546-558
- 52 Hartley PS. The diurnal tick-tockery of platelet biology. Platelets 2012; 23 (02) 157-160
- 53 Talens S, Malfliet JJ, Rudež G. , et al. Biological variation in tPA-induced plasma clot lysis time. Thromb Haemost 2012; 108 (04) 640-646
- 54 Lordkipanidzé M. Platelet function tests. Semin Thromb Hemost 2016; 42 (03) 258-267
- 55 Paglieroni TG, Janatpour K, Gosselin R. , et al. Platelet function abnormalities in qualified whole-blood donors: effects of medication and recent food intake. Vox Sang 2004; 86 (01) 48-53
- 56 Pearson DA, Paglieroni TG, Rein D. , et al. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res 2002; 106 (4-5): 191-197
- 57 Miller GJ. Dietary fatty acids and the haemostatic system. Atherosclerosis 2005; 179 (02) 213-227
- 58 Sy E, Sklar MC, Lequier L, Fan E, Kanji HD. Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care 2017; 39: 87-96
- 59 Winkler AM. Managing the precarious hemostatic balance during extracorporeal life support: implications for coagulation laboratories. Semin Thromb Hemost 2017; 43 (03) 291-299
- 60 Bartoli CR, Kang J, Zhang D. , et al. Left ventricular assist device design reduces von Willebrand factor degradation: a comparative study between the HeartMate II and the EVAHEART left ventricular assist system. Ann Thorac Surg 2017; 103 (04) 1239-1244
- 61 Gosselin R, Dager W, Roberts A. , et al. Effect of telavancin (Vibativ) on routine coagulation test results. Am J Clin Pathol 2011; 136 (06) 848-854
- 62 Webster PS, Oleson Jr FB, Paterson DL. , et al. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results. Blood Coagul Fibrinolysis 2008; 19 (01) 32-38
- 63 Centers for Disease Control and Prevention. Clinical action bulletin. April 2018. Available at: https://content.govdelivery.com/accounts/USCDC/bulletins/1eb9503 . Accessed March 2019
- 64 King N, Tran MH. Long-acting anticoagulant rodenticide (Superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management. Transfus Med Rev 2015; 29 (04) 250-258
- 65 Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 1994; 44 (06) 793-797
- 66 Stegnar M, Cuderman TV, Bozic M. Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability. Clin Chem Lab Med 2007; 45 (01) 40-46
- 67 Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Sodium citrate vacuum tubes validation: preventing preanalytical variability in routine coagulation testing. Blood Coagul Fibrinolysis 2013; 24 (03) 252-255
- 68 Bowen RA, Adcock DM. Blood collection tubes as medical devices: the potential to affect assays and proposed verification and validation processes for the clinical laboratory. Clin Biochem 2016; 49 (18) 1321-1330
- 69 Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M. ; British Committee for Standards in Haematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 2013; 35 (01) 1-13
- 70 Lima-Oliveira G, Lippi G, Salvagno GL. , et al. Processing of diagnostic blood specimens: is it really necessary to mix primary blood tubes after collection with evacuated tube system?. Biopreserv Biobank 2014; 12 (01) 53-59
- 71 Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (pediatric) tubes. Chest 2004; 126 (04) 1262-1266
- 72 Giavarina D, Lippi G. Blood venous sample collection: recommendations overview and a checklist to improve quality. Clin Biochem 2017; 50 (10-11): 568-573
- 73 CLSI. Collection of Diagnostic Venous Blood Specimens. 7th ed. Standard GP41. Wayne, PA: Clinical and Laboratory Standards Institute; 2017
- 74 Ong ME, Chan YH, Lim CS. Observational study to determine factors associated with blood sample haemolysis in the emergency department. Ann Acad Med Singapore 2008; 37 (09) 745-748
- 75 Uman LS, Birnie KA, Noel M. , et al. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev 2013; (10) CD005179
- 76 World Health Organization. WHO guidelines on drawing blood: best practices in phlebotomy. Available at: https://www.ncbi.nlm.nih.gov/books/NBK138650/pdf/Bookshelf_NBK138650.pdf . Accessed March 2019
- 77 Kang HJ, Han CD, Jahng JS, Ko SO. Blood gas and electrolyte changes after tourniquet application in total knee replacement surgery. Yonsei Med J 1992; 33 (02) 153-158
- 78 Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. Am J Clin Pathol 1998; 109 (05) 595-599
- 79 Phelan MP, Reineks EZ, Berriochoa JP. , et al. Impact of use of smaller volume, smaller vacuum blood collection tubes on hemolysis in emergency department blood samples. Am J Clin Pathol 2017; 148 (04) 330-335
- 80 Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997; 107 (01) 105-110
- 81 Bovill EG, Terrin ML, Stump DC. , et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 1991; 115 (04) 256-265
- 82 Kadani M. , B N V S S, B M, , et al. Evaluation of plasma fibrinogen degradation products and total serum protein concentration in oral submucous fibrosis. J Clin Diagn Res 2014; 8 (05) ZC54-ZC57
- 83 Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag 2014; 10: 75-87
- 84 Raijmakers MT, Menting CH, Vader HL, van der Graaf F. Collection of blood specimens by venipuncture for plasma-based coagulation assays: necessity of a discard tube. Am J Clin Pathol 2010; 133 (02) 331-335
- 85 Douxfils J, Ageno W, Samama CM. , et al. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost 2018; 16 (02) 209-219
- 86 Marlar RA, Potts RM, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol 2006; 126 (03) 400-405
- 87 Salvagno GL, Lippi G, Montagnana M, Franchini M, Poli G, Guidi GC. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol 2009; 31 (04) 462-467
- 88 Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008; 99 (02) 416-426
- 89 Gosselin RC, Adcock DM, Bates SM. , et al. International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost 2018; 118 (03) 437-450
- 90 van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005; 51 (03) 561-568
- 91 Glas M, Mauer D, Kassas H, Volk T, Kreuer S. Sample transport by pneumatic tube system alters results of multiple electrode aggregometry but not rotational thromboelastometry. Platelets 2013; 24 (06) 454-461
- 92 Hübner U, Böckel-Frohnhöfer N, Hummel B, Geisel J. The effect of a pneumatic tube transport system on platelet aggregation using optical aggregometry and the PFA-100. Clin Lab 2010; 56 (1-2): 59-64
- 93 Wallin O, Söderberg J, Grankvist K, Jonsson PA, Hultdin J. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation. Clin Chem Lab Med 2008; 46 (10) 1443-1449
- 94 CLSI. Platelet Function Testing by Aggregometry. 1st ed. H58A. Wayne, PA: Clinical and Laboratory Standards Institute; 2008
- 95 Chapman K, Favaloro EJ. Time dependent reduction in platelet aggregation using the multiplate analyser and hirudin blood due to platelet clumping. Platelets 2018; 29 (03) 305-308
- 96 Lippi G, Rossi R, Ippolito L. , et al. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples. Semin Thromb Hemost 2013; 39 (07) 834-839
- 97 Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J 2016; 14: 49-53
- 98 Nelson S, Pritt A, Marlar RA. Rapid preparation of plasma for ‘Stat’ coagulation testing. Arch Pathol Lab Med 1994; 118 (02) 175-176
- 99 Foshat M, Bates S, Russo W. , et al. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels. Clin Appl Thromb Hemost 2015; 21 (01) 41-47
- 100 Gosselin RC, Dwyre DW. Determining the effect of freezing on coagulation testing: comparison of results between fresh and once frozen-thawed plasma. Blood Coagul Fibrinolysis 2015; 26 (01) 69-74
- 101 Odsæter IH, Lian IA, Bratberg K, Mikkelsen G. Dry ice exposure of plasma samples influences pH and lupus anticoagulant analysis. Clin Chem Lab Med 2015; 53 (05) 809-813
- 102 Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost 2013; 39 (03) 258-266
- 103 D'Angelo G, Villa C, Tamborini A, Villa S. Evaluation of the main coagulation tests in the presence of hemolysis in healthy subjects and patients on oral anticoagulant therapy. Int J Lab Hematol 2015; 37 (06) 819-833
- 104 Lippi G, Montagnana M, Salvagno GL, Guidi GC. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med 2006; 130 (02) 181-184
- 105 Jahr JS, Lurie F, Gosselin R, Lin JS, Wong L, Larkin E. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on coagulation testing. Clin Lab Sci 2000; 13 (04) 210-214
- 106 Jahr JS, Liu H, Albert OK. , et al. Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study. Am J Ther 2010; 17 (02) 140-147